Arbutus Biopharma Corp·4

Feb 19, 8:04 AM ET

Collier William H. 4

4 · Arbutus Biopharma Corp · Filed Feb 19, 2020

Insider Transaction Report

Form 4
Period: 2020-02-17
Collier William H.
DirectorPresident and CEO
Transactions
  • Award

    Stock Options

    2020-02-17+367,087367,087 total
    Exercise: $3.35Exp: 2030-02-17Common Stock (367,087 underlying)
Footnotes (1)
  • [F1]The stock option will vest and become exercisable 1/48th each month over the four year period.

Documents

2 files
  • 4
    wf-form4_158211745366536.xmlPrimary

    FORM 4

  • EX-24

    POA - COLLIER